Business Wire06.11.20
Endologix Inc., a developer and marketer of innovative treatments for aortic disorders, has appointed Tim A. Benner to succeed John Zehren as the company’s chief commercial officer.
Benner brings to Endologix over a decade of commercial, sales and marketing, strategy, and business development experience in the medical device industry. Most recently, he served as general manager and division vice president of the U.S. Region for Abbott’s Structural Heart business. While at Abbott, he directed the U.S. commercial organization with responsibility for sales, marketing, and the P&L across the TMVr (MitraClip), Structural Interventions (Amplatzer), Surgical Valves, and TAVR franchises. Prior to that, he spent nine years at Edwards Lifesciences in positions of increasing responsibility in Strategy, Business Development, Global Marketing, Commercial Operations, and Market Development. Benner also served on Edwards’ senior leadership team.
John Onopchenko, CEO of Endologix, commented, “We are thrilled to welcome Tim to our executive team. He has demonstrated a strong track-record of achievement in the medical device industry, implementing a number of successful commercial strategies across a variety of unique product families and markets. We are excited to have Tim on board to spearhead our commercial strategy and put AFX2, Ovation, Alto, Nellix, and ChEVAS in the hands of physicians around the globe.”
Benner added, “I’m excited to join the Endologix team, and I strongly believe that we can leverage the company’s portfolio to capitalize on the many opportunities in the EVAR market. I look forward to working with the Endologix team to drive the procedural growth that will generate outcomes data and bring our life-saving technology to patients in need.”
Benner earned his MBA from the University of California, Irvine, conducted graduate-level MS-BA coursework at the University of Southern California, and completed his bachelor of science degree in business administration from California State University, Long Beach.
Benner brings to Endologix over a decade of commercial, sales and marketing, strategy, and business development experience in the medical device industry. Most recently, he served as general manager and division vice president of the U.S. Region for Abbott’s Structural Heart business. While at Abbott, he directed the U.S. commercial organization with responsibility for sales, marketing, and the P&L across the TMVr (MitraClip), Structural Interventions (Amplatzer), Surgical Valves, and TAVR franchises. Prior to that, he spent nine years at Edwards Lifesciences in positions of increasing responsibility in Strategy, Business Development, Global Marketing, Commercial Operations, and Market Development. Benner also served on Edwards’ senior leadership team.
John Onopchenko, CEO of Endologix, commented, “We are thrilled to welcome Tim to our executive team. He has demonstrated a strong track-record of achievement in the medical device industry, implementing a number of successful commercial strategies across a variety of unique product families and markets. We are excited to have Tim on board to spearhead our commercial strategy and put AFX2, Ovation, Alto, Nellix, and ChEVAS in the hands of physicians around the globe.”
Benner added, “I’m excited to join the Endologix team, and I strongly believe that we can leverage the company’s portfolio to capitalize on the many opportunities in the EVAR market. I look forward to working with the Endologix team to drive the procedural growth that will generate outcomes data and bring our life-saving technology to patients in need.”
Benner earned his MBA from the University of California, Irvine, conducted graduate-level MS-BA coursework at the University of Southern California, and completed his bachelor of science degree in business administration from California State University, Long Beach.
